Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

IMDX

Insight Molecular Diagnostics Inc.

CIK 0001642380 · Nasdaq

NasdaqHealth CareIn Vitro & In Vivo Diagnostic Substances
$4.85
↑ 0.06 (1.25%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options

Key stats

Market Cap
$156.61M
P/E Ratio
-3.27
EPS
-1.65
Dividend Yield
Not covered
52W Position
41%
Beta
2.48

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-14.65
P/S
80.35
EV/Revenue
65.88
ROE
447.5%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 41%
$2.33$8.51

Latest Financials

2025-12-31 FY
Revenue
$4.05M
Net Income
-$50.22M
Total Assets
$25.76M
Free Cash Flow
-$25.37M

Recent news